Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004305 · ClinicalTrials.gov registry record
Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- 105
- Enrollment target
NCT00004305 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 105 participants.
The verdict
NCT00004305 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine whether allelic differences associated with the fourth component of complement, type-1 complement receptor expressed on erythrocytes, and Fc receptor FcgRIII contribute to the pathogenesis of IgA glomerulonephritis (IgA-N). II. Compare genetic anomalies of these key components in immune complex processing and clearance between juvenile vs adult onset IgA-N vs normal controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 1998-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004305
The ClinicalTrials.gov registry entry for NCT00004305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00004305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004305 about?
NCT00004305 is a clinical study titled "Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis". OBJECTIVES: I. Determine whether allelic differences associated with the fourth component of complement, type-1 complement receptor expressed on erythrocytes, and Fc receptor FcgRIII contribute to the pathogenesis of IgA glomerulonephritis (IgA-N). II. Compare genetic anomalies of these key compone...
What is the current status of trial NCT00004305?
This trial is currently completed. The enrollment target is 105 participants. The study started on 1998-01.
Who is sponsoring clinical trial NCT00004305?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.